Advertisement

Topics

AZ's Lynparza shows PARP inhibitor potential in breast cancer

07:20 EDT 6 Jun 2017 | PMLIVE

Findings were presented at the American Society of Clinical Oncology (ASCO) meeting in Chicago

Original Article: AZ's Lynparza shows PARP inhibitor potential in breast cancer

NEXT ARTICLE

More From BioPortfolio on "AZ's Lynparza shows PARP inhibitor potential in breast cancer"

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...